Overview

To Demonstrate the Relative Bioavailability Study of Loratadine 10 mg Tablets

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
To demonstrate the relative bioavailability study of Loratadine 10 mg tablets.
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Loratadine